OR indicates overall response; PFS, progression-free survival; R/R, relapsed/refractory; MCL, mantle cell lymphoma; CR, complete response; FL, follicular lymphoma; WM, Waldenstrom's macroglobulinemia; NHL, non-Hodgkin's lymphoma; DLBCL, diffuse large B-cell lymphoma; RCHOP, rituximab, cyclophosphamide, adriamycin, vincristine, prednisone; DA-REPOCH, dose adjusted rituximab, etoposide, prednisone, vincristine, cyclophosphamide, adriamycin; RICE, rituximab, ifosfamide, cisplatin, etoposide; and RDHAP, rituximab, dexamethasone, cytarabine, cisplatin.